Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuing experience with chemonucleolysis.

E J Nordby1, M J Javid

  • 1University of Wisconsin, Department of Neurological Surgery, Madison 53792, USA.

The Mount Sinai Journal of Medicine, New York
|October 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction: chemonucleolysis symposium.

Orthopedics·2014
Same author

Chemonucleolysis: the state of the art.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2001
Same author

Long-term follow-up review of patients who underwent laminectomy for lumbar stenosis: a prospective study.

Journal of neurosurgery·1998
Same author

Chondroitinase ABC (pharmaceutical grade) for chemonucleolysis spine.

Spine·1997
Same author

Postchemonucleolysis discectomy versus repeat discectomy: a prospective 1- to 13-year comparison.

Journal of neurosurgery·1996
Same author

Chemonucleolysis.

Spine·1996
Same journal

Farewell message from Penny A. Asbell, MD, FACS, MBA, Editor-in-Chief of the Mount Sinai Journal of Medicine.

The Mount Sinai journal of medicine, New York·2012
Same journal

Minority undergraduate programs intended to increase participation in biomedical careers.

The Mount Sinai journal of medicine, New York·2012
Same journal

Future of electronic health records: implications for decision support.

The Mount Sinai journal of medicine, New York·2012
Same journal

AA amyloidosis: Mount Sinai experience, 1997-2012.

The Mount Sinai journal of medicine, New York·2012
Same journal

Amyloid neuropathies.

The Mount Sinai journal of medicine, New York·2012
Same journal

Should your family history of coronary heart disease scare you?

The Mount Sinai journal of medicine, New York·2012
See all related articles

Chemonucleolysis using chymopapain offers a minimally invasive treatment for herniated lumbar discs. This technique is as effective as laminectomy, with improved safety and cost-effectiveness for selected patients.

Area of Science:

  • Neurosurgery
  • Minimally Invasive Procedures
  • Biologics

Background:

  • Herniated lumbar discs are a common cause of low back pain.
  • Surgical interventions like laminectomy carry risks and significant costs.
  • Chymopapain injections have been explored as an alternative treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety of chemonucleolysis with chymopapain for lumbar disc herniation.
  • To compare chemonucleolysis outcomes with traditional surgical methods.
  • To assess the cost-effectiveness of this minimally invasive approach.

Main Methods:

  • A national multicenter, double-blind study was conducted.
  • Patients with herniated lumbar discs were appropriately selected.

Related Experiment Videos

  • Chymopapain injections were administered and outcomes compared to laminectomy.

    • Main Results:

    • Chemonucleolysis with chymopapain demonstrated success rates comparable to laminectomy.
    • The procedure resulted in fewer complications than laminectomy.
    • Significant cost savings were observed with chemonucleolysis.

    Conclusions:

    • Chemonucleolysis using chymopapain is a viable and effective treatment for selected patients with herniated lumbar discs.
    • This minimally invasive technique offers a favorable risk-benefit profile and cost advantages over laminectomy.
    • Despite past controversy, chymopapain injections provide a valuable therapeutic option in spine care.